$6.99
2.04% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US1266381052
Symbol
CVRX

CVRx Inc Stock price

$6.99
+0.93 15.35% 1M
-6.53 48.30% 6M
-5.68 44.83% YTD
-1.29 15.58% 1Y
+1.74 33.14% 3Y
-21.01 75.04% 5Y
-21.01 75.04% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.14 2.04%
ISIN
US1266381052
Symbol
CVRX
Sector

Key metrics

Market capitalization $182.25m
Enterprise Value $130.00m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.46
P/S ratio (TTM) P/S ratio 3.45
P/B ratio (TTM) P/B ratio 2.63
Revenue growth (TTM) Revenue growth 25.62%
Revenue (TTM) Revenue $52.87m
EBIT (operating result TTM) EBIT $-50.70m
Free Cash Flow (TTM) Free Cash Flow $-41.57m
Cash position $102.67m
EPS (TTM) EPS $-2.19
P/E forward negative
P/S forward 3.25
EV/Sales forward 2.32
Short interest 7.05%
Show more

Is CVRx Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

CVRx Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a CVRx Inc forecast:

6x Buy
86%
1x Sell
14%

Analyst Opinions

7 Analysts have issued a CVRx Inc forecast:

Buy
86%
Sell
14%

Financial data from CVRx Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
53 53
26% 26%
100%
- Direct Costs 9.43 9.43
33% 33%
18%
43 43
24% 24%
82%
- Selling and Administrative Expenses 83 83
8% 8%
157%
- Research and Development Expense 11 11
6% 6%
20%
-50 -50
5% 5%
-95%
- Depreciation and Amortization 0.67 0.67
29% 29%
1%
EBIT (Operating Income) EBIT -51 -51
5% 5%
-96%
Net Profit -52 -52
1% 1%
-98%

In millions USD.

Don't miss a Thing! We will send you all news about CVRx Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CVRx Inc Stock News

Neutral
Seeking Alpha
10 days ago
CVRx, Inc. (NASDAQ:CVRX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Kevin Hykes - President & CEO Jared Oasheim - CFO Mike Vallie - IR, ICR Healthcare Conference Call Participants Macauley Kilbane - William Blair Nelson Cox - Lake Street Capital Markets Chase Knickerbocker - Craig-Hallum Capital Group Ross Osborn - Cantor Fitzgerald Operator Good day, everyone...
Neutral
GlobeNewsWire
26 days ago
MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that it plans to release first quarter 2025 financial and operating results after market close on Thursday, May 8, 2025. The Company will host a conference call to review its results at 4:30pm Eastern Time the same day.
Positive
Seeking Alpha
about one month ago
CVRx Inc. stock has recently dropped 40%, presenting a buying opportunity as the long-term growth potential remains intact. Barostim has strong clinical results and significant market potential, with a $2.2 billion TAM. Average selling prices can potentially improve as the market recognizes Barostim's effectiveness.
More CVRx Inc News

Company Profile

CVRx, Inc. develops proprietary active implantable technology to treat high blood pressure and heart failure. It has developed the second generation Barostim neo, an implantable system designed to treat heart failure and hypertension. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2000 and is headquartered in Minneapolis, MN.

Head office United States
CEO Kevin Hykes
Employees 206
Founded 2001
Website www.cvrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today